Ad is loading...
NBHAX
Price
$14.76
Change
+$0.09 (+0.61%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

NBHAX vs VVIAX

Header iconNBHAX vs VVIAX Comparison
Open Charts NBHAX vs VVIAXBanner chart's image
Neuberger Berman Equity Income A
Price$14.76
Change+$0.09 (+0.61%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
NBHAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBHAX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBHAX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. NBHAX (974M). VVIAX pays higher dividends than NBHAX: VVIAX (2.36) vs NBHAX (1.66). NBHAX was incepted earlier than VVIAX: NBHAX (16 years) vs VVIAX (24 years). NBHAX is a more actively managed with annual turnover of: 30.00 vs. VVIAX (10.00). NBHAX has a lower initial minimum investment than VVIAX: NBHAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. NBHAX (20.45). VVIAX return over 5 years is better than : 53.09 vs. NBHAX (19.57).
NBHAXVVIAXNBHAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years24 years-
Gain YTD18.24619.67293%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets974M184B1%
Annual Yield % from dividends1.662.3671%
Returns for 1 year20.4526.0978%
Returns for 3 years-1.0624.77-4%
Returns for 5 years19.5753.0937%
Returns for 10 years26.60112.2624%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics